Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rangering i aksjer #33467
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aksjekurs
$0.5099
Sist synkronisert: 2024-10-15
Markedsverdi
$7.60M
Endring (1 dag)
2.02%
Endring (1 år)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Kategori

Inntekter for Anew Medical, Inc. (WENA)
Inntekter i Jun 2024 TTM: 0.00
Ifølge de nyeste økonomiske rapportene til Anew Medical, Inc. er selskapets nåværende inntekter (TTM) 0.00. I 2022 hadde selskapet inntekter på 0.00 lik inntektene i 2021, som var 0.00. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Anew Medical, Inc. fra 2021 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE